PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Yeungnam University Journal of Medicine10.12701/yujm.2019.00171201936267-77Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiologyIn Cheol Yoon, Jong Ryeol Eunhttp://yujm.yu.ac.kr/upload/pdf/yujm-2019-00171.pdf, http://yujm.yu.ac.kr/journal/view.php?doi=10.12701/yujm.2019.00171, http://yujm.yu.ac.kr/upload/pdf/yujm-2019-00171.pdf
Journal of Gastroenterology and Hepatology10.1111/j.1440-1746.2011.07018.x20122758-64Pathophysiology guided treatment of nonalcoholic steatohepatitisTuyet A T Nguyen, Arun J Sanyalhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2011.07018.x
Clinics in Liver Disease10.1016/j.cld.2017.08.007201822123-37Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic SteatohepatitisVignan Manne, Priya Handa, Kris V. Kowdleyhttps://api.elsevier.com/content/article/PII:S1089326117300685?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1089326117300685?httpAccept=text/plain
Clinics in Liver Disease10.1016/j.cld.2009.07.0012009134667-688Pharmacologic Therapy of Non-Alcoholic SteatohepatitisVlad Ratziu, Shira Zelber-Sagihttps://api.elsevier.com/content/article/PII:S1089326109000531?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1089326109000531?httpAccept=text/plain
Hepatology10.1002/hep.234732009512366-369Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?Stephen A. Harrisonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.23473
Hepatology Research10.1111/j.1872-034x.2011.00780.x2011413209-216Pharmacological therapy of nonalcoholic steatohepatitisMariko Hojo, Sumio Watanabehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2011.00780.x
Gastroenterology10.1016/s0016-5085(11)62925-920111405S-704Pharmacological Therapy of Nonalcoholic Steatohepatitis-Systematic ReviewMariko Hojo, Akihito Nagahara, Daisuke Asaoka, Hitoshi Sasaki, Sumio Watanabehttps://api.elsevier.com/content/article/PII:S0016508511629259?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508511629259?httpAccept=text/plain
Hepatology10.1002/hep.2469620115451503-1505Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?Kathleen E. Corey, Naga Chalasanihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.24696, https://onlinelibrary.wiley.com/doi/full/10.1002/hep.24696
Gastroenterology10.1053/j.gastro.2008.02.077200813461682-1698Diagnosis and Therapy of Nonalcoholic SteatohepatitisDawn M. Torres, Stephen A. Harrisonhttps://api.elsevier.com/content/article/PII:S0016508508003508?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508508003508?httpAccept=text/plain
Advances in Therapy10.1007/s12325-013-0084-6201431130-43Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD)Iliana Doycheva, Rohit Loombahttp://link.springer.com/content/pdf/10.1007/s12325-013-0084-6.pdf, http://link.springer.com/article/10.1007/s12325-013-0084-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12325-013-0084-6